r.szabo
TL2 · Beirut
Contributes reviews on supplier material. Based in Beirut.
Joined 30 December 2024 · last posted 9d
77 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #44 · Access › Insurance & coverage · 19 Jul 2026 · 4 likes I read the earlier replies on Prior authorisation twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…
-
Packaging that arrived damaged: documenting it properly Replied, post #42 · Sourcing › Logistics · 14 Jul 2026 · 0 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…
-
Journal club: what we got wrong in an earlier session Replied, post #74 · Evidence › Journal club · 11 Jul 2026 · 22 likes The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.
-
How to ask a question when you cannot say why you are asking it Replied, post #37 · Start Here › How to Ask · 11 Jul 2026 · 21 likes Context that matters: compound, how long in, current dose, relevant history. Context that does not matter: how you feel, your hopes for the outcome, your medical…
-
Alcohol: what is documented and what is folklore Replied, post #100 · Practice › Interactions · 8 Jul 2026 · 1 like I changed my mind about alcohol after someone here asked me for the source and I could not produce one. That is worth saying out loud because it is the ordinary way it…
-
Revisiting: The best-written scientific paper you have read Replied, post #57 · Lounge › Off topic · 28 Jun 2026 · 5 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors.
-
Constipation management, with a dietitian's contribution Replied, post #83 · Practice › Side effects · 24 Jun 2026 · 27 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
What published stability data actually covers, and what it does not Replied, post #5 · Practice › Storage & stability · 7 Jun 2026 · 0 likes Marking my place. If it changes for me I will come back and say so.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #44 · Practice › Storage & stability · 1 Jun 2026 · 5 likes Confirming post #43 from a second method, which matters more than confirming it from a second person. Visible particulate is a strong signal in the other direction: it…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #59 · Practice › Reconstitution · 26 May 2026 · 0 likes Picking up post #58: that is the part I would want checked first. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a…
-
Transporting a vial for a weekend away — a second dataset Replied, post #61 · Practice › Storage & stability · 23 May 2026 · 0 likes That reframing is the whole thing. The facts I already had.
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #23 · Analytics › Home & field testing · 20 May 2026 · 21 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Hair shedding at month three: mechanism and time course — the long version Replied, post #10 · Practice › Side effects · 12 May 2026 · 3 likes I have been on both sides of the Hair shedding argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Peak-to-trough ratio at steady state for a weekly agent — the long version Replied, post #2 · Pharmacology › Pharmacokinetics · 9 May 2026 · 17 likes Steady state is approached in roughly four to five half-lives. For a compound with a week-long half-life that is four to five weeks, which is where the escalation…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #56 · Practice › Administration · 9 May 2026 · 11 likes Adding the measurement that post #54 says would settle it. Pinching a fold is useful for lean tissue and unnecessary elsewhere. The point is to keep the needle out of…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #21 · Practice › Reconstitution · 18 Apr 2026 · 0 likes Preservative effectiveness is tested against a defined microbial challenge under defined conditions. It is not a licence to treat an entered vial as sterile…
-
List price versus negotiated price versus what you pay Replied, post #111 · Access › Pricing · 17 Apr 2026 · 17 likes Picking up post #110: that is the part I would want checked first. The failure mode on list price versus negotiated price is boring rather than dramatic. It is almost…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #101 · Practice › Reconstitution · 16 Apr 2026 · 3 likes Post #98 is the version of this I will quote in future. One addition. Bacteriostatic water contains benzyl alcohol; sterile water for injection does not. The difference…
-
Restarting after a long gap: what the labelling implies — the long version Replied, post #11 · Practice › Dosing & titration · 15 Apr 2026 · 10 likes A titration plan written down in advance is easier to stick to and easier to abandon deliberately. An improvised one becomes a series of decisions made on the worst day…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #78 · Practice › Reconstitution · 28 Mar 2026 · 21 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Grapefruit: why this class is not the class that cares Replied, post #71 · Practice › Interactions · 23 Mar 2026 · 21 likes Adding the measurement that post #68 says would settle it. Oral contraceptive absorption has been studied specifically for some compounds in this class and the findings…
-
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #68 · Start Here › How to Ask · 27 Feb 2026 · 18 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #36 · Sourcing › Logistics · 10 Feb 2026 · 18 likes This follows post #35 rather than contradicting it. Split shipments reduce single-point risk and increase the number of transits. Which trade is right depends on what…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #21 · Outcomes › Progress reports · 8 Feb 2026 · 14 likes Answering the Seven-day rolling question as asked, then the question I think is meant. As asked: yes, with the qualification below. As meant: it depends on how the…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #81 · Access › Pricing · 5 Feb 2026 · 8 likes I read post #79 twice before replying, because I had assumed the opposite. One caution on Price changes: everything above assumes the underlying documentation is what…
-
When to stop reading forums, including this one Replied, post #80 · Wellbeing › Mental health · 24 Jan 2026 · 5 likes Post #78 put the caveat in the right place and I want to underline it. Mood changes reported during substantial weight loss have several plausible contributors and the…
-
Pre-registering a personal experiment, seriously — a second dataset Replied, post #21 · Research Methods › N-of-1 designs · 16 Jan 2026 · 31 likes Pre-registering a personal experiment is a good example of a question where the honest answer is boring and the interesting answers are unsupported. I would go with…
-
Waist circumference technique and its repeatability Replied, post #36 · Outcomes › Progress reports · 8 Jan 2026 · 0 likes Post #32 put the caveat in the right place and I want to underline it. Nothing here is medical advice and a progress report is a description of what happened to one…
-
Second pass at: What to keep a record of at the point of payment Started this topic · Sourcing › Payments · 4 Jan 2026 · 0 likes Second pass at: What to keep a record of at the point of payment — setting out what I have, and where I think it stops being reliable. A payments question, with the…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #82 · Practice › Interactions · 3 Jan 2026 · 1 like This is the answer, and the reason it is the answer is the more useful part.
-
What "verified" means on our vendor pages, stated narrowly Replied, post #30 · Sourcing › Vendor reports · 2 Jan 2026 · 0 likes Answering the question post #28 raises rather than the one it answers. The cost of a submission is worth stating. It is the main reason people do not do this and…
-
Follow-up: A supplier that answers analytical questions with restated claims Replied, post #30 · Sourcing › Red flags · 29 Dec 2025 · 25 likes Post #27 is the version of this I will quote in future. One addition. Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure"…
-
Tracking a preprint to publication: a worked example Replied, post #3 · Evidence › Preprints · 28 Nov 2025 · 27 likes On the opening post — agreed on the reasoning, with one qualification. Sample size and pre-registration are checkable in a preprint exactly as in a paper, and they…
-
Pen dose counters: what a click does and does not guarantee Replied, post #32 · Devices › Pens & autoinjectors · 14 Nov 2025 · 1 like Visibility of the dose: some pens allow you to see the insulin remaining; others do not. Keeping track using the dose counter is important if visibility is limited. The…
-
Thyroid function tests during substantial weight change Replied, post #115 · Clinical › Bloodwork · 30 Oct 2025 · 22 likes Two things can be true about thyroid function tests during substantial at once: the mechanism is plausible and the evidence for the size of the effect is thin. Most of…
-
A 40-week log with the measurement method stated Replied, post #3 · Outcomes › Progress reports · 12 Oct 2025 · 0 likes The version of 40-week log that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #44 · Analytics › COA interpretation · 30 Sep 2025 · 0 likes A certificate of analysis is a statement by its issuer that a defined test was performed on a defined lot and produced a defined result. That is all it is, and it is…
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #47 · Practice › Storage & stability · 21 Sep 2025 · 11 likes I had written a reply contradicting post #43 and deleted it. Here is what survived. Visible particulate is a strong signal in the other direction: it is a reason to…
-
What a regulator's shortage notice actually authorises — what changed since Replied, post #8 · Sourcing › Regulatory · 20 Sep 2025 · 0 likes The arithmetic in post #7 is right; the assumption feeding it is the part to check. An indication approved for one age range does not extend to another, and paediatric…
-
[2026 update] A single out-of-range value on an otherwise normal panel Replied, post #11 · Clinical › Bloodwork · 19 Sep 2025 · 23 likes I read post #7 twice before replying, because I had assumed the opposite. Rate of change is frequently more informative than absolute value, and it is only available if…
-
Revisiting: Power cut for eleven hours: how I assessed it afterwards Started this topic · Practice › Storage & stability · 17 Sep 2025 · 50 likes Revisiting: Power cut for eleven hours: how I assessed it afterwards — setting out what I have, and where I think it stops being reliable. A follow-up question about…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #14 · Data & Tools › Datasets · 6 Sep 2025 · 19 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.…
-
An emergency department visit, described afterwards Replied, post #62 · Safety › Adverse events · 3 Sep 2025 · 16 likes Fair, and the limits you put on it are the part I will remember.
-
Second pass at: Why this subcategory is stricter about sourcing than most Replied, post #68 · Compounds › Secretagogues & GH axis · 16 Aug 2025 · 0 likes Adding the measurement that post #67 says would settle it. A mass result for a short peptide is more discriminating than for a long one, because a single residue…
-
Revisiting: GLP-1 receptor distribution: central and peripheral Replied, post #26 · Pharmacology › Receptor biology · 11 Aug 2025 · 13 likes GLP-1 receptor agonism produces its metabolic effects through more than one route: central satiety signalling, delayed gastric emptying, and glucose-dependent insulin…
-
Asking about a compound your prescriber has not heard of Replied, post #122 · Clinical › Prescriber conversations · 11 Aug 2025 · 0 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations.
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #3 · Compounds › Semaglutide · 23 Jul 2025 · 5 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
[2026 update] Constipation management, with a dietitian's contribution Replied, post #11 · Practice › Side effects · 16 Jul 2025 · 22 likes Marking my uncertainty on Constipation management explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Escalating every six weeks instead of four: what I observed over eight months — one year… Replied, post #41 · Practice › Dosing & titration · 13 Jul 2025 · 12 likes Picking up post #38: that is the part I would want checked first. Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add…
-
Coming back to: Why semaglutide solutions can look faintly opalescent and when that… Replied, post #18 · Compounds › Semaglutide · 5 Jul 2025 · 1 like Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #74 · Practice › Storage & stability · 28 Jun 2025 · 13 likes The documentation on published stability data actually covers is better than this thread and I say that as someone who has posted in the thread.
-
IGF-1 as a surrogate endpoint and its limitations — the long version Replied, post #8 · Compounds › Secretagogues & GH axis · 14 Jun 2025 · 16 likes Injection-site reactions are reported more often in this family than for the incretins. Whether that is the compounds or the preparations they are typically supplied in…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #84 · Access › Insurance & coverage · 12 Jun 2025 · 7 likes An update on my earlier appeal post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #10 · Compounds › Cagrilintide & amylin analogues · 4 Jun 2025 · 2 likes Narrowing post #9, because the general version has more than one answer. Combination products complicate the certificate question considerably. Two active components…
-
Publishing an inconvenient result: a case study Replied, post #26 · Sourcing › Independent verification · 28 May 2025 · 22 likes I read post #22 twice before replying, because I had assumed the opposite. Where the publishing an inconvenient result discussion usually stalls is that nobody wants to…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #67 · Compounds › Secretagogues & GH axis · 22 May 2025 · 20 likes An honest declaration on Tesamorelin: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
-
Pregnancy as an absolute contraindication Replied, post #82 · Safety › Contraindications · 20 May 2025 · 26 likes Picking up post #81: that is the part I would want checked first. Pregnancy: these compounds are not approved for pregnancy. The potential risks outweigh potential…
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #39 · Clinical › Comorbidities · 13 May 2025 · 0 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Follow-up: What other technical communities get right that we do not Replied, post #94 · Lounge › Off topic · 11 May 2025 · 10 likes Something I have wondered without ever asking: is there a good reason the vocabulary in this field is so inconsistent between suppliers? Half the disagreements here…
-
Revisiting: Filing a first vendor report: a worked example Started this topic · Sourcing › Vendor reports · 8 May 2025 · 8 likes On the subject in the title: Revisiting: Filing a first vendor report: a worked example Working notes rather than a conclusion. A question about Filing a first vendor…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #36 · Data & Tools › Calculators · 27 Apr 2025 · 10 likes Why calculators are not medical advice: they do arithmetic. Medical decisions are not arithmetic. A calculator that says a certain dose is "compatible with" a certain…
-
A newcomer's list of things that confused me, and the fixes Replied, post #9 · Start Here › Welcome · 20 Apr 2025 · 0 likes Muting is under-used here. A category you mute stops appearing in Latest for you, and you can unmute it in a second. Most long-term members read four or five categories…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #52 · Practice › Reconstitution · 17 Apr 2025 · 6 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Publishing an inconvenient result: a case study Replied, post #7 · Sourcing › Independent verification · 11 Apr 2025 · 0 likes Combining a chromatographic result with a documentation review gives a more complete picture than two chromatographic results, because the failure modes are different.…
-
Scheduled maintenance and what will be unavailable Replied, post #96 · Meta › Announcements · 3 Apr 2025 · 7 likes Good question, well framed, and I would like to see it answered properly.
-
Random versus fixed effects: choosing rather than defaulting — a second dataset Replied, post #87 · Evidence › Meta-analyses · 10 Feb 2025 · 5 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. I have deliberately…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #4 · Wellbeing › Mental health · 8 Feb 2025 · 27 likes The most useful thing anyone has posted about history of disordered eating in this category was a table of what had been measured and by whom. That is what I would want…
-
Isotonicity and what happens when you get it wrong Replied, post #17 · Pharmacology › Formulation chemistry · 4 Jan 2025 · 0 likes Everything in post #15 holds. The case it does not cover is the one I have. Something worth flagging about isotonicity: the strongest-sounding claims in this thread are…
-
Dose numbers for oral formulations are not comparable to injectable ones — a second… Replied, post #16 · Compounds › Oral incretins · 3 Jan 2025 · 2 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Revisiting: Moderation log format change Replied, post #61 · Meta › Announcements · 9 Dec 2024 · 6 likes The arithmetic on Moderation log format change is the easy part and it is where the errors are, which is an uncomfortable combination. Show your working and someone…
-
Why "any advice?" is the least effective ending for a post Replied, post #98 · Start Here › How to Ask · 2 Dec 2024 · 22 likes Disagreement-style questions: "I read this and it contradicts what I heard here, which is right?" is answerable. "Is this a bad idea?" without giving the context is not.
-
Second pass at: A field-by-field walk through a certificate of analysis Replied, post #132 · Analytics › COA interpretation · 28 Nov 2024 · 0 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #42 · Clinical › Prescriber conversations · 8 Nov 2024 · 0 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Coming back to: Grapefruit: why this class is not the class that cares Replied, post #11 · Practice › Interactions · 25 Sep 2024 · 0 likes Offering a way to settle Grapefruit rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is within the…
-
Promotion criteria, and the one that stops most nominations Replied, post #48 · Documentation › Doc review · 28 Aug 2024 · 1 like Post #45 is the version of this I will quote in future. One addition. Point three stops most nominations. A document without a maintainer becomes wrong quietly, and…
-
Cold packs, phase-change material, and what survives ten days Replied, post #114 · Sourcing › Logistics · 17 Jul 2024 · 29 likes Insurance and carrier liability: most parcel carriers limit liability. Understanding the limits before choosing a carrier matters if you are shipping expensive material.
-
Assessing a warm arrival: the decision process — one year on Replied, post #132 · Sourcing › Logistics · 2 Jun 2024 · 22 likes One caution on Assessing a warm arrival: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely…